TheMetabolic Syndrome, type II Diabetes and Atherosclerosis Congress brings together cardiologists, diabetologists and scientists to discuss therapeutic managements and prevention of type II Diabetes, Metabolic Syndrome and Atherosclerosis.
Topics
- Metabolic syndrome: risk factors and pharmacotherapy
- Role in chronic diseases diabetes as a model
- Prevalence of metabolic syndrome in Middle East
- Pharmacotherapy for the management of metabolic syndrome
- Hypertriglyceridemia: therapeutic challenges
- Management of HDL-C in patients with diabetes and metabolic syndrome
- Pathogenesis and risk factors for atrial fibrillation
- Prevention of the vascular complications of diabetes type II
- Triglycerides, HDL-C and the risk of coronary disease
- Primary and secondary prevention of stroke in atrial fibrillation
- The risk versus benefits of standard and emerging antiplatelet therapies
- Hypertension and CV risk reduction in patients with diabetes
- Metabolic syndrome, diabetes and their complications
- Advances in the clinical management of lipids and glucose for the prevention of CVD in metabolic diseases
